CNCR vs. IBBQ

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while IBBQ tracks the NASDAQ / Biotechnology. Both are passively managed. CNCR charges 0.79%/yr vs 0.00%/yr for IBBQ.

Performance

CNCR vs. IBBQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Invesco Nasdaq Biotechnology ETF (IBBQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IBBQ

• 1D: 0.93%
• 1M: 5.09%
• YTD: 8.67%
• 6M: 7.00%
• 1Y: 48.86%
• 3Y*: 15.18%
• 5Y*: 4.77%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. IBBQ - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
IBBQ Invesco Nasdaq Biotechnology ETF	6.92%

CNCR vs. IBBQ - Sectors Allocation Comparison

Sectors	CNCR	IBBQ
Healthcare	96.6%	99.9%
Financial Services	3.3%	0.1%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. IBBQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

IBBQ

IBBQ Risk / Return Rank: 83
IBBQ Sharpe Ratio Rank: 81
IBBQ Sortino Ratio Rank: 80
IBBQ Omega Ratio Rank: 71
IBBQ Calmar Ratio Rank: 92
IBBQ Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. IBBQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	IBBQ	Difference
Sharpe ratio: Return per unit of total volatility	—	2.45	—
Sortino ratio: Return per unit of downside risk	—	3.36	—
Omega ratio: Gain probability vs. loss probability	—	1.40	—
Calmar ratio: Return relative to maximum drawdown	—	5.89	—
Martin ratio: Return relative to average drawdown	—	18.75	—

Drawdowns

CNCR vs. IBBQ - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum IBBQ drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for CNCR and IBBQ.

Drawdown Indicators

	CNCR	IBBQ	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-37.94%	+37.94%
Max Drawdown (1Y) Largest decline over 1 year	—	-8.34%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-23.66%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-37.94%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	-16.66%	+16.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	2.61%	—

Volatility

Volatility by Period

	CNCR	IBBQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.82%	—
Volatility (6M) Calculated over the trailing 6-month period	—	15.72%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	20.03%	-20.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	21.92%	-21.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	21.87%	-21.87%

CNCR vs. IBBQ - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than IBBQ's 0.00% expense ratio.

Dividends

CNCR vs. IBBQ - Dividend Comparison

CNCR has not paid dividends to shareholders, while IBBQ's dividend yield for the trailing twelve months is around 0.83%.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IBBQ Invesco Nasdaq Biotechnology ETF	0.83%	0.90%	1.14%	0.81%	0.76%	0.63%

Frequently Asked Questions

Which ETF is better, CNCR or IBBQ?

On fees, IBBQ is cheaper at 0.00% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or IBBQ?

IBBQ is cheaper with a 0.00% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or IBBQ?

IBBQ has the higher dividend yield at 0.83%, compared with 0.00% for CNCR.

What is the main difference between CNCR and IBBQ?

CNCR tracks Loncar Cancer Immunotherapy Index, while IBBQ tracks NASDAQ / Biotechnology. They also come from different issuers: Exchange Traded Concepts and Invesco. Their fees differ too: 0.79% for CNCR and 0.00% for IBBQ.